Related Experiment Video
Updated: May 11, 2026

A Protocol for Explant Cultures of IDH1-mutant Diffuse Low-grade Gliomas
Published on: May 9, 2025
Releasing the block: setting differentiation free with mutant IDH inhibitors
Christopher J Pirozzi1, Zachary J Reitman, Hai Yan
1The Preston Robert Tisch Brain Tumor Center at Duke, Pediatric Brain Tumor Foundation Institute at Duke, Department of Pathology, Duke University Medical Center, Durham, NC 27710, USA.
Abstract:
Hotspot mutations in IDH1 and IDH2 cause a differentiation block that can promote tumorigenesis. Two recent papers reported that small molecules targeting mutant IDH1 or mutant IDH2 release this differentiation block and/or impede tumor growth, providing a proof-of-concept that mutant IDHs are therapeutically targetable and that their effects are reversible.
More Related Videos
Related Concept Videos
Forced Transdifferentiation
Artificial transdifferentiation occurs...
In-vitro Mutagenesis

